Qianming Du

机构：Nanjing University of Chinese Medicine, China Pharmaceutical University, Nanjing General Hospital of Nanjing Military Command, Institute of Physiology and Basic Medicine · ORCID：0000-0002-1092-2899

发表论文 66 篇 · 总被引 2396 次 · h-index 26

代表论文

• Single-cell analyses reveal cannabidiol rewires tumor microenvironment via inhibiting alternative activation of macrophage and synergizes with anti-PD-1 in colon cancer (2023 · Journal of Pharmaceutical Analysis · 被引 55)
• Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment (2023 · International Journal of Biological Macromolecules · 被引 44)
• Fabrication of a Polysaccharide-Protein/Protein Complex Stabilized Oral Nanoemulsion to Facilitate the Therapeutic Effects of 1,8-Cineole on Atherosclerosis (2023 · ACS Nano · 被引 38)
• SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer (2023 · Pharmacological Research · 被引 33)
• Intercellular adhesion molecule-1 suppresses TMZ chemosensitivity in acquired TMZ-resistant gliomas by increasing assembly of ABCB1 on the membrane (2024 · Drug Resistance Updates · 被引 27)
• FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression (2024 · Cell Death and Disease · 被引 22)